Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
The POPADAD (Prevention Of Progression of Arterial Disease And Diabetes) study did not show a benefit for low-dose aspirin therapy or administration of antioxidants for the primary prevention of cardiovascular disease events in individuals with diabetes and asymptomatic peripheral arterial disease....
Main Authors: | Price, H, Holman, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
Aspirin for primary prevention of cardiovascular disease in diabetes
by: Ying Xing, et al.
Published: (2019-07-01) -
Role of aspirin in primary prevention of cardiovascular disease
by: Patrono, C, et al.
Published: (2019) -
PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN DIABETES MELLITUS: THE ROLE OF ASPIRIN
by: L. A. Strizhakov
Published: (2012-04-01) -
Cost-effectiveness analysis of aspirin for primary prevention of cardiovascular events among patients with type 2 diabetes in China.
by: Minghuan Jiang, et al.
Published: (2019-01-01) -
Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events
by: Sylvester KW, et al.
Published: (2013-05-01)